PCMA and NACDS respond to PBM reform legislation in Illinois
The legislation includes banning spread pricing and requiring PBMs to pass 100% of manufacturer rebates to health plans or patients.
Pharmacy
Senate narrowly passes Trump budget deal with deep healthcare cuts
The CBO estimates the legislation, which now heads to the House, would result in 11.8 million Americans losing health insurance by 2034.
Moderna’s flu vaccine shows positive late-stage trial results, could lead to combination COVID shot
"An mRNA-based flu vaccine has the potential advantage to more precisely match circulating strains, support rapid response in a future influenza pandemic, and pave the way for COVID-19 combination vaccines."
NCPA laments SCOTUS decision to punt on Oklahoma PBM reform
Court’s inaction creates confusion in the states.
PCMA supports FTC/DOJ listening session on Big Pharma patent abuse
PCMA voiced support for a series of legislative and regulatory reforms.
Hikma to spend $1 billion to expand generic drug manufacturing and R&D in the U.S.
The new investment phase builds on over 34 years years of serving the needs of U.S. patients and healthcare providers.
Revolutionizing adherence: Clinical trials go digital with enhanced Key-Pak
Key-Pak with Med-Con integration delivers cost-effective digital monitoring—boosting compliance, improving data quality, and empowering study teams.
Hawai'i Pharmacists Association and APhA celebrate passage of landmark legislation
This legislation mandates that beginning July 1, 2026, private and public health plans in Hawai'i must reimburse licensed pharmacists for covered health services of contracted pharmacists when those services are delivered within pharmacists' scope of practice.
CHPA welcomes new board members at June meeting
“Each brings a wealth of leadership experience, strategic insight, and a deep commitment to consumer health and wellness.”
NACDS urges Congress act as key PBM reforms are stripped from budget bill
The removed provisions—a ban on PBM spread pricing in Medicaid managed care and a reimbursement rate floor—were included in both the House bill and the Senate Finance Committee's version.
RFK Jr.’s new vaccine advisers to re-examine shot advice for children
Changes to the schedule could limit access to certain immunizations
CDC’s Advisory Committee on Immunization concludes meeting with joint statement
"This committee is not in competition with other committees, organizations, or each other – we are all in competition with the infectious diseases and we will work together to ensure the best outcomes for public health."
CVS Caremark must pay $95M in Medicare fraud case
Eastern District of Pennsylvania Judge Mitchell Goldberg ruled that Caremark inflated Medicare Part D prices to offset other costs.
PillSafe appoints Lon G. von Hurwitz to spearhead brand modernization and market strategy for 2026 launch
The appointment comes as PillSafe readies its product for commercial launch in early 2026.
Cardinal Investor Day 2025: Momentum, strong performance and multi-year growth
Members of its leadership team shared their strategies to continue to maximize the company’s potential, including making multiple investments in new facilities featuring the latest automation, technology-enabled customer solutions, and strategic acquisitions.
HHS Secretary Kennedy, CMS Administrator Oz secure industry pledge to fix broken prior authorization system
In a roundtable discussion hosted by HHS, health insurers pledged six key reforms aimed at cutting red tape, accelerating care decisions, and enhancing transparency for patients and providers.